This thread is for the discussion of and exchange of information on MRSA which is becoming more and more of an epidemic. Information on companies involved in the battle against MRSA is welcome and encouraged, but persistent hyping of a stock is not.
Some companies involved with MRSA (please help build the list):
Antibiotics:
Merck - investigating platensimycin, finance.yahoo.com
Theravence, Inc - investigational antibiotic telavancin finance.yahoo.com
Astellas Pharma, inc - telavancin (with Theravence) - astellas.us
Paratek Pharmaceuticals - investigational antibiotic PTK 0796 (with Merck), privately held paratekpharm.com
Targanta Therapeutics - investigational antibiotic oritavancin - IPO filed targanta.com
Replidyne, Inc., REP8839 topical antibiotic finance.yahoo.com
Other treatment:
Oculus - wound healing, finance.yahoo.com
Derma Sciences, Inc. - MRSA-effective bandages, finance.yahoo.com
Ondine Biopharma Corp http - Photodynamic Disinfection - finance.yahoo.com
Rapid Identification:
Cepheid - Xpert MRSA test finance.yahoo.com
Acolyte Biomedica (owned by 3M) - BacLite Rapid MRSA acolytebiomedica.com
Accelr8 Technology - finance.yahoo.com
BD Diagnostics - BD GeneOhm StaphSR assay - finance.yahoo.com
Johns Hopkins' basic MRSA info for patients: hopkinsmedicine.org
cdc.gov
HA-MRSA - Healthcare Acquired MRSA
CA-MRSA - Community Acquired MRSA
VRSA - Vancomycin-resistant Staphylococcus aureus |
